Lantheus Holdings, Inc. (LNTH)
99.97
-0.22
(-0.22%)
USD |
NASDAQ |
Oct 06, 16:00
99.97
0.00 (0.00%)
After-Hours: 20:00
Lantheus Holdings Cash from Operations (Quarterly) : 92.20M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.20M |
| March 31, 2026 | 125.13M |
| December 31, 2025 | 90.18M |
| September 30, 2025 | 105.29M |
| June 30, 2025 | 87.11M |
| March 31, 2025 | 107.56M |
| December 31, 2024 | 155.40M |
| September 30, 2024 | 175.06M |
| June 30, 2024 | 84.72M |
| March 31, 2024 | 127.24M |
| December 31, 2023 | 112.29M |
| September 30, 2023 | 116.74M |
| June 30, 2023 | -32.27M |
| March 31, 2023 | 108.50M |
| December 31, 2022 | 105.35M |
| September 30, 2022 | 93.57M |
| June 30, 2022 | 72.60M |
| March 31, 2022 | 10.26M |
| December 31, 2021 | 13.89M |
| September 30, 2021 | 4.34M |
| June 30, 2021 | 25.87M |
| March 31, 2021 | 9.818M |
| December 31, 2020 | 5.569M |
| September 30, 2020 | 5.145M |
| June 30, 2020 | -3.726M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.408M |
| December 31, 2019 | 22.42M |
| September 30, 2019 | 26.44M |
| June 30, 2019 | 21.05M |
| March 31, 2019 | 10.47M |
| December 31, 2018 | 17.31M |
| September 30, 2018 | 24.28M |
| June 30, 2018 | 20.28M |
| March 31, 2018 | -0.666M |
| December 31, 2017 | 13.09M |
| September 30, 2017 | 15.60M |
| June 30, 2017 | 20.57M |
| March 31, 2017 | 5.524M |
| December 31, 2016 | 12.78M |
| September 30, 2016 | 15.45M |
| June 30, 2016 | 17.64M |
| March 31, 2016 | 3.78M |
| December 31, 2015 | 12.63M |
| September 30, 2015 | 5.417M |
| June 30, 2015 | -11.44M |
| March 31, 2015 | 15.16M |
| December 31, 2014 | -3.875M |
| September 30, 2014 | 20.51M |
| June 30, 2014 | -4.988M |
| March 31, 2014 | -0.06M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Biomerica, Inc. | -0.912M |
| Univec, Inc. | -0.0157M |
| Indivior Pharmaceuticals, Inc. | 228.52M |
| Zomedica Corp. | -2.515M |
| Bristol Myers Squibb Co. | 3.393B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.023M |
| Cash from Financing (Quarterly) | 4.505M |
| Free Cash Flow | 382.42M |
| Free Cash Flow Per Share (Quarterly) | 1.331 |
| Free Cash Flow to Equity (Quarterly) | 90.66M |
| Free Cash Flow to Firm (Quarterly) | 93.80M |
| Free Cash Flow Yield | 5.73% |